1. Vitamin E administration at the onset of fever prevents renal scarring in acute pyelonephritis.
- Author
-
Sadeghi Z, Kajbafzadeh AM, Tajik P, Monajemzadeh M, Payabvash S, and Elmi A
- Subjects
- Acute Disease, Animals, Male, Pyelonephritis pathology, Rats, Rats, Wistar, Transforming Growth Factor beta biosynthesis, Antioxidants therapeutic use, Cicatrix prevention & control, Fever drug therapy, Kidney pathology, Pyelonephritis complications, Vitamin E therapeutic use
- Abstract
We evaluated the protective effects of antioxidant at the onset of fever on renal damage in a rat model of acute pyelonephritis. Twenty rats were allocated to four groups. In groups 1 to 3, the animals were given direct inoculation of Escherichia coli into the right kidney, and group four served as control. All rats in groups 1 to 3 were given once-daily intraperitoneal injections of ceftriaxon for five consecutive days, beginning on the third day after inoculation. The animals' body temperatures were monitored; as soon as body temperature reaches 38 degrees C, the rats in group 2 were given allopurinol co-treatment, whereas, in group 3, vitamin E co-treatment was started at fever onset. Both kidneys were excised 6 weeks later, for the evaluation of histopathologic changes, apoptotic damage, and concentrations of transforming growth factor-beta (TGF-beta). Only minimal changes were found in control samples. Pathologic scores of inflammation and fibrosis in group 1 were higher than in the vitamin E and allopurinol groups (P < 0.05). Apoptosis index was also decreased in groups 2 and 3, compared to group 1 (P < 0.05). There was no significant difference in average TGF-beta levels between study groups. These findings suggest that administration of vitamin E or allopurinol following the onset of fever can reduce renal damage in pyelonephritis.
- Published
- 2008
- Full Text
- View/download PDF